The future of ACT in cancer treatment looks promising, with ongoing research aimed at broadening its applicability and improving its effectiveness. Clinical trials are underway to explore its use in various cancer types and in combination with other therapies. As our understanding of the immune system and cancer biology continues to evolve, ACT is expected to play an increasingly important role in the oncologic landscape.
